About 16 million Americans have rosacea, a chronic inflammatory skin condition centered on the central face. The classic image — a flushed, ruddy complexion with visible blood vessels and acneiform bumps on the cheeks and nose — captures only part of the picture. Rosacea includes burning, stinging, dryness, eye irritation, and in severe cases, the bulbous nose enlargement (rhinophyma) sometimes mistakenly attributed to alcoholism.
The condition typically begins between ages 30 and 50 and is more common in fair-skinned people of Northern European descent, though it occurs across all skin types. Rosacea cannot be cured, but well-chosen treatment can dramatically reduce visible signs and frequency of flares, according to the NIAMS. This guide covers the four subtypes, evidence-based treatment options, and the trigger management strategies that often matter as much as any prescription.
What Rosacea Is
Rosacea is a chronic inflammatory disorder of the central face involving vascular, immune, and neural components. The exact cause is unknown, but contributing factors include innate immune dysregulation (cathelicidin overactivity), demodex mite colonization, vascular hyperreactivity, and skin barrier dysfunction. There is a genetic predisposition; about a third of patients have a family member affected.
Modern classification by phenotype rather than rigid subtypes acknowledges that features overlap. The four traditional subtypes still appear in clinical use: erythematotelangiectatic, papulopustular, phymatous, and ocular. For broader context on inflammatory skin conditions, see our overview of medical conditions and the eczema guide for differential considerations.
The Four Subtypes
Erythematotelangiectatic rosacea
Persistent central facial redness with episodes of flushing and visible small dilated blood vessels (telangiectasias). Skin often feels burning or stinging. This is the most common subtype.
Papulopustular rosacea
Persistent redness with inflamed papules and pustules that can resemble acne but typically lack comedones (blackheads and whiteheads). Acne and rosacea can coexist.
Phymatous rosacea
Skin thickening with enlarged pores, most commonly on the nose (rhinophyma) but sometimes on chin, forehead, ears, or eyelids. More common in men, often after years of untreated disease.
Ocular rosacea
Eye irritation, dryness, burning, foreign-body sensation, redness, and recurrent styes or chalazia. Affects up to 50 percent of rosacea patients, sometimes preceding skin manifestations.
Common Triggers
Rosacea triggers are highly individual, but the most commonly reported include sun exposure, hot weather, cold wind, hot drinks, alcohol (especially red wine), spicy foods, stress, vigorous exercise, hot baths, and certain skincare ingredients (alcohol, fragrance, menthol, witch hazel, exfoliants). Identifying personal triggers and modifying exposure cuts flare frequency for most patients.
Topical and systemic vasodilators including some blood pressure medications can worsen flushing. Topical steroids should generally be avoided on rosacea-affected skin — they reduce inflammation briefly but cause rebound worsening and steroid-induced rosacea with prolonged use.
Skin Care Basics
Gentle cleansing twice daily with a non-soap fragrance-free cleanser is the foundation. Cetaphil Gentle Skin Cleanser, CeraVe Hydrating Cleanser, and Vanicream Gentle Facial Cleanser are commonly recommended. Pat dry rather than rubbing. Apply a fragrance-free moisturizer with ceramides daily. Sunscreen — broad-spectrum SPF 30 or higher, ideally with mineral filters (zinc oxide, titanium dioxide) to reduce irritation — is non-negotiable. UV is one of the most common triggers and a long-term driver of vascular damage in the face.
Avoid scrubs, exfoliants, and astringents. Patch test new products on the inner forearm for several days before applying to the face.
Topical Treatments
For erythema, topical brimonidine (Mirvaso) and oxymetazoline (Rhofade) constrict blood vessels and reduce redness for 8 to 12 hours. They don’t treat underlying inflammation and may produce rebound redness in some users. For papules and pustules, topical metronidazole 0.75 to 1 percent, azelaic acid 15 to 20 percent, and ivermectin 1 percent (Soolantra) are first-line. Soolantra targets demodex mites and has shown superiority to metronidazole in head-to-head trials.
Newer entrants include topical minocycline foam (Zilxi) for inflammatory rosacea. According to the American Academy of Dermatology, combination therapy — for example, a vasoconstrictor for redness plus an anti-inflammatory for papules — often works better than monotherapy.
Oral Medications
Doxycycline is the most commonly prescribed oral therapy for inflammatory rosacea. Sub-antimicrobial doxycycline (40 mg modified-release once daily, branded as Oracea) targets inflammation without the antibacterial effect, reducing antibiotic resistance concerns and side effects. Standard-dose doxycycline (50 to 100 mg twice daily) is sometimes used short-term for severe flares.
For refractory papulopustular rosacea, oral isotretinoin at low doses (10 to 40 mg/day) shows substantial benefit but requires the iPLEDGE program due to teratogenicity. Other options include oral metronidazole, tetracycline, and minocycline. Beta-blockers (carvedilol, propranolol) at low doses help selected patients with severe flushing.
Light and Laser Treatments
Telangiectasias and persistent erythema respond best to vascular laser and intense pulsed light (IPL). Pulsed dye laser (PDL) and KTP laser target hemoglobin and reduce visible vessels and background redness. Most patients need 2 to 4 treatments, spaced 4 to 6 weeks apart, with maintenance every 1 to 2 years. Costs run $300 to $600 per session and are typically not covered by insurance because they are considered cosmetic.
For phymatous changes, CO2 laser, electrosurgery, and surgical debulking remove excess tissue and reshape the nose or affected area. Outcomes are excellent in experienced hands but the procedure is rarely covered by insurance unless functional impairment is documented.
Ocular Rosacea
Eye involvement requires its own treatment plan. Warm compresses, eyelid hygiene with diluted baby shampoo or commercial eyelid cleansers, and artificial tears help mild cases. Oral doxycycline is effective for moderate-to-severe ocular rosacea. Topical cyclosporine (Restasis) and lifitegrast (Xiidra) are sometimes added for chronic dry eye. Severe cases need ophthalmology comanagement to prevent corneal complications. Cleveland Clinic publishes detailed ocular rosacea protocols.
When to seek emergency care: Call 911 or go to the nearest emergency room if you experience sudden severe eye pain with vision loss, severe facial swelling with breathing difficulty, or signs of cellulitis with fever and rapidly spreading redness — these are not routine rosacea complications and require urgent evaluation.
When to See a Doctor
Persistent facial redness lasting more than a few weeks, recurrent acne-like bumps in adulthood (especially without comedones), or chronic eye irritation in someone with facial flushing should prompt dermatology consultation. Rosacea is sometimes mistaken for acne, lupus, or contact dermatitis; an experienced dermatologist gets the diagnosis quickly and prevents inappropriate treatment.
Frequently Asked Questions
Is rosacea caused by alcohol?
No. Alcohol can trigger rosacea flares but does not cause the disease. The historical association with alcoholism stems from rhinophyma being visible in some heavy drinkers; the actual causation runs the other direction. Many lifelong nondrinkers have severe rosacea.
Can rosacea go away on its own?
Mild rosacea sometimes remits spontaneously but most cases are chronic and progressive without treatment. Trigger avoidance and good skincare can substantially reduce visible disease, but underlying vascular and inflammatory tendencies usually persist.
Is rosacea contagious?
No. Rosacea is not infectious. The demodex mites associated with it are normal skin flora, present in most adults; rosacea patients simply harbor higher densities and react to them more.
What is the difference between rosacea and lupus?
Lupus can produce a malar rash that mimics rosacea, but typically spares the nasolabial folds and is associated with systemic features (joint pain, fatigue, photosensitivity, kidney involvement). Rosacea is a skin-only condition without systemic disease. Lab testing distinguishes them when the diagnosis is unclear.
The Bottom Line
Rosacea is best managed by combining strict trigger control, gentle skin care with daily mineral sunscreen, targeted topicals for the dominant features, and laser or IPL for vascular damage. Oral therapy bridges severe flares. The biggest mistake is trying to “scrub away” rosacea with exfoliants and acne products — that approach reliably worsens the condition. Gentle, consistent care plus a dermatologist familiar with rosacea phenotypes typically produces dramatic visible improvement within 3 to 6 months.